Ruxolitinib is effective in treating certain types of disorders of blood and bone marrow disease. Your treating healthcare doctor may also prescribe the brand version of Ruxolitinib i.e. namely Jakafi and Jakavi. Jakafi/Jakavi drugs comes in dosage strengths of 5 mg, 15 mg, and 20 mg. The advised (initial) dose for Jakafi/Jakavi is (determined on the current platelet count of a patient and (which the treating healthcare physician may adjust as per the condition of the patient) may additionally be adjusted with the aid of the consulting Doctor, as needed. Jakafi/Jakavi is normally suggested to be taken 2 times in a day (by mouth i.e. orally), either (with a meal or without food).

Content Source - https://www.genuinedrugs123.com/121-Anti-Cancer-Drugs-Generic-Ruxolitinib-Phosphate-Brand-Jakafi.aspx

Ruxolitinib 5 mg Tablet (Brand JAKAFI/JAKAVI, Novartis)

Ruxolitinib 10 mg Tablet (Brand JAKAFI/JAKAVI, Novartis)

Ruxolitinib 15 mg Tablet (Brand JAKAFI/JAKAVI, Novartis)

Ruxolitinib 20 mg Tablet (Brand JAKAFI/JAKAVI, Novartis)